In our cohort, we found that the presence of clinical symptoms of hyperprolactinemia was one of the most predictive factors in diagnosing a cystic pituitary adenoma compared to an RCC, independent of serum prolactin level and lesion size. This evidence concerns the gene PRL and hyperprolactinemia.